Ireland-based pharmaceutical company Allergan, through its subsidiaries Allergan Sales and Celestial Merger Sub, has agreed to acquire US-based development-stage biopharmaceutical company Repros Therapeutics.

Celestial Merger will purchase all outstanding shares of common stock of Repros Therapeutics for $0.67 a share, under the agreement.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The transaction was announced in December and will be closed in the first quarter of 2018.

Philippines-based life science equipment and services provider Philab Holdings plans to purchase a 67% share in pharmaceutical firm Sydenham Laboratories.

Philab will roll out a precision medicine programme post acquisition, which will boost the synergies of the two companies in the healthcare sector.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now